|
RNASEH2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.691980E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.687800E-02 |
| Normal-vs-Stage2 |
1.055930E-03 |
| Normal-vs-Stage3 |
1.004020E-01 |
| Normal-vs-Stage4 |
1.490190E-02 |
| Stage1-vs-Stage2 |
6.500000E-03 |
| Stage1-vs-Stage3 |
4.385800E-01 |
| Stage1-vs-Stage4 |
7.888000E-02 |
| Stage2-vs-Stage3 |
4.385800E-01 |
| Stage2-vs-Stage4 |
8.433200E-01 |
| Stage3-vs-Stage4 |
6.912200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.039900E-02 |
| Normal-vs-AfricanAmerican |
1.063860E-02 |
| Normal-vs-Asian |
2.929800E-01 |
| Caucasian-vs-AfricanAmerican |
2.051400E-01 |
| Caucasian-vs-Asian |
9.572000E-01 |
| AfricanAmerican-vs-Asian |
6.548200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.578500E-02 |
| Normal-vs-Female |
1.844480E-03 |
| Male-vs-Female |
4.155900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.464700E-03 |
| Normal-vs-Extreme_Weight |
5.502100E-02 |
| Normal-vs-Obese |
1.675910E-02 |
| Normal-vs-Extreme_Obese |
4.136200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.459900E-02 |
| Normal_Weight-vs-Obese |
4.517600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.922600E-01 |
| Extreme_Weight-vs-Obese |
3.414600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.428800E-01 |
| Obese-vs-Extreme_Obese |
4.622600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.189200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.857400E-03 |
| Normal-vs-Age(61-80Yrs) |
6.222200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.023800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.442500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.212000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.304000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.609700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.408200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.695300E-03 |
| Normal-VS-Type2 PRCC |
1.881600E-02 |
| Normal-VS-KIRP CIMP |
5.307600E-01 |
| Normal-VS-Unclassified PRCC |
6.424100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.217800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.229600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.388800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.788100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.728400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.670400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.451700E-02 |
| Normal-vs-N1 |
1.350110E-02 |
| Normal-vs-N2 |
5.990600E-01 |
| N0-vs-N1 |
1.137440E-01 |
| N0-vs-N2 |
2.238000E-01 |
| N1-vs-N2 |
1.811760E-01 |
|
|
